Evidence map›Paper›PMID 36612598›Full record

ArticleInternational journal of environmental research and public health2022

The Dandarah App: An mHealth Platform to Tackle Violence and Discrimination of Sexual and Gender Minority Persons Living in Brazil.

Angélica Baptista Silva, Mônica Malta, Cosme Marcelo Furtado Passos da Silva, Clarice Cavalcante Kalume, Ianê Germano Andrade Filha, Sara LeGrand, Kathryn Whetten

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Do we urologists know enough about gender minorities with prostate cancer?International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Angélica Baptista SilvaDepartment of Human Rights, Health and Cultural Diversity, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-0292-5106
Mônica MaltaInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON M5S 2S1, Canada.ORCID 0000-0001-7634-6671
Cosme Marcelo Furtado Passos da SilvaDepartment of Epidemiology and Quantitative Methods in Health, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
Clarice Cavalcante KalumeDepartment of Human Rights, Health and Cultural Diversity, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
Ianê Germano Andrade FilhaDepartment of Human Rights, Health and Cultural Diversity, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
Sara LeGrandCenter for Health Policy and Inequalities Research, Duke Global Health Institute, Duke University, Durham, NC 27710, USA.
Kathryn WhettenCenter for Health Policy and Inequalities Research, Duke Global Health Institute, Duke University, Durham, NC 27710, USA.
Escola Nacional de Saúde Pública · BRDuke University · USCentre for Addiction and Mental Health · CAFundação Oswaldo Cruz · BR

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
RISE Study ("Resist, Intervene, Support, Empower"): Feasibility/Acceptability of MHealth Intervention targeting Transgender Women facing gender-based violence and mental health disorders in BrazilR21MH119496 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MALTA, MONICA · 2020 to 2021
$339k
NIAID NIH HHS P30 AI064518NIMH NIH HHS R21 MH119496
6 · The paper itself

Abstract

Discrimination and violence are widely experienced by sexual and gender minority (SGM) persons worldwide. More than one SGM person is murdered every day in Brazil because of their sexuality or gender identity, which is the highest reported homicide rate in the world. Alt-hough discrimination and violence against SGM persons in Brazil are considered to be hate crimes, reporting is still suboptimal due to fear of police SGM phobia and victim blaming. Accessible and easily disseminated interventions are urgently needed. Herein, we describe the develop-ment of an mHealth solution to help address violence against SGM persons, namely the Rainbow Resistance: Dandarah App, with a synthesis of key results and feedback from the SGM community after 24 months of using the app. Twenty-two focus group discussions (FGDs) were conducted with SGM persons living in six Brazilian states: Bahia, Federal District, São Paulo, Rio de Janeiro, Minas Gerais, Sergipe, and Pará. A total of 300 SGM persons participated in the FGDs. A thematic analysis was performed to interpret the qualitative data. Content themes related to aesthetics, us-ability, barriers to resources, and likes/dislikes about the intervention arose from the FGDs. Participants found the intervention to be user-friendly, endorsed more likes than dislikes, and suggested a few changes to the app. The findings suggest that the intervention is usable and fit for future ef-fectiveness testing, and that it could fill an important gap in the well-being of SGM persons living in a country with high levels of discrimination and violence towards this community, i.e., Brazil.

Indexed as

Mobile ApplicationsSexual and Gender MinoritiesTelemedicineBrazilFemaleGender IdentityHumansMaleSexual BehaviorViolenceappdigital healthdiscriminationdomestic violencegender-based violenceLGBTLGBTQmHealthmobile healthsexual and gender minority (SGM)sexual violenceviolence

Identifiers

PMID36612598
PMCPMC9819566
OpenAlexW4313245075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.